Ken Griffin Psychemedics Corp Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Psychemedics Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 21,509 shares of PMD stock, worth $50,331. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,509
Previous 12,640
70.17%
Holding current value
$50,331
Previous $30,000
63.33%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PMD
# of Institutions
20Shares Held
1.24MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA276KShares$645,9190.72% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny271KShares$633,8190.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA251KShares$588,0020.0% of portfolio
-
Rbf Capital, LLC San Francisco, CA142KShares$332,6120.02% of portfolio
-
Black Rock Inc. New York, NY71KShares$166,1840.0% of portfolio
About PSYCHEMEDICS CORP
- Ticker PMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 5,626,200
- Market Cap $13.2M
- Description
- Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, ...